• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 86 pages
Exam (elaborations)

NSG 533 Advanced Pharmacology Final Exam Study Guide Wilkes University High-Yield Pharmacology 150 Q&A + Rationales 2026/2027

Document preview thumbnail
Preview 4 out of 86 pages

Verified NSG 533 Advanced Pharmacology Final Exam Study Guide | Wilkes University | Q & A | 2026/2027 Edition (PDF) resource featuring exam-focused questions, NGN-style case studies, and complete rationales. Comprehensive coverage spans foundational pharmacokinetics and pharmacodynamics (ADME, CYP450 metabolism, receptor theory), autonomic nervous system therapeutics, cardiovascular and renal pharmacotherapy (antihypertensives, ARNIs, antiarrhythmics, anticoagulants), respiratory agents, psychotropic and neurological pharmacology, antimicrobial therapy, endocrine regimens, and special populations management (geriatrics, pediatrics, renal/hepatic impairment, pregnancy). Emphasis on advanced practice clinical decision-making, prescriptive authority reasoning, therapeutic drug monitoring, patient safety, and exam alignment. Ideal for students searching NSG 533 Advanced Pharmacology Final Exam PDF, Wilkes University Study Guide, NSG 533 Test Bank, NSG 533 Verified Answers, NSG 533 Exam Prep 2026/2027, NSG 533 Practice Test Workbook, and Wilkes University Graduate Nursing Exams.

Content preview

,NSG 533 Advanced Pharmacology Final Exam
Study Guide Wilkes University High-Yield
Pharmacology 150 Q&A + Rationales
2026/2027
1. A 70 kg patient receives a 350 mg IV bolus of a drug. The plasma concentration is measured
at 5 mg/L. What is the volume of distribution (Vd)?



A. 7 L

B. 35 L

C. 70 L

D. 350 L



Correct Answer: C. 70 L



Rationale: Vd = Dose / Plasma Concentration. Vd = 350 mg ÷ 5 mg/L = 70 L. The volume of
distribution reflects the extent of drug distribution into body tissues relative to plasma.




2. A patient with cirrhosis and ascites is prescribed a hydrophilic drug. Which change in drug
distribution is most likely?



A. Decreased Vd for water-soluble drugs

B. Increased Vd for hydrophilic drugs

C. Increased protein binding

,D. Decreased Vd for lipophilic drugs



Correct Answer: B. Increased Vd for hydrophilic drugs



Rationale: Cirrhosis and ascites increase total body water, expanding the volume into which
hydrophilic drugs distribute. This increases the Vd of water-soluble drugs, potentially requiring
higher loading doses.




3. A patient with heart failure has reduced hepatic blood flow. This will most significantly affect
clearance of which drug?



A. Gentamicin

B. Lidocaine

C. Lithium

D. Digoxin



Correct Answer: B. Lidocaine



Rationale: Lidocaine is a high-extraction-ratio drug, meaning its hepatic clearance is highly
dependent on liver blood flow. Reduced hepatic perfusion in heart failure significantly
decreases lidocaine clearance, increasing toxicity risk.




4. A drug follows zero-order kinetics. Which statement is correct?

, A. Half-life is constant

B. Doubling the dose doubles the time to eliminate

C. Elimination rate is proportional to concentration

D. Dose-dependent toxicity is a concern



Correct Answer: D. Dose-dependent toxicity is a concern



Rationale: Zero-order kinetics occurs when metabolic enzymes are saturated. A constant
amount of drug is eliminated per unit time regardless of concentration. Small dose increases
can cause disproportionately large increases in plasma concentration, leading to toxicity.
Examples include phenytoin, ethanol, and high-dose aspirin.




5. A patient with hypoalbuminemia is prescribed a highly protein-bound drug. What is the most
likely clinical consequence?



A. Decreased free drug concentration and reduced efficacy

B. Increased free drug concentration and toxicity risk

C. No change in free drug concentration

D. Increased renal excretion of the drug



Correct Answer: B. Increased free drug concentration and toxicity risk



Rationale: Low albumin reduces protein binding sites, increasing the free (active) fraction of
highly protein-bound drugs. This can cause toxicity even at standard doses. Dose reduction and
monitoring are often necessary.

Document information

Uploaded on
September 24, 2026
Number of pages
86
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$15.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
3
Followers
1
Items
379
Last sold
1 day ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions